<DOC>
	<DOCNO>NCT00474552</DOCNO>
	<brief_summary>Primary : To assess safety tolerability ascend multiple oral dos SAM-315 , investigational drug , healthy young adult elderly subject . Secondary : To assess Pharmacokinetic Pharmacodynamic profile multiple oral dos SAM-315 healthy young adult elderly subject .</brief_summary>
	<brief_title>Study Evaluating Safety , Tolerability , Pharmacokinetics , Pharmacodynamics SAM-315</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Young healthy subject : Men woman nonchildbearing potential ( WONCBP ) age 18 45 year inclusive study day 1 . Body mass index ( BMI ) range 18 30 kg/m2 body weight great equal 50 kg body weight great equal 50 kg . Elderly Healthy subject : Men woman age 65 year study day 1 . BMI range 18 30 kg/m2 body weight great equal 45 kg body weight great equal 45 kg . Any significant cardiovascular , hepatic , renal , respiratory , gastrointestinal , endocrine , immunologic , dermatologic , hematologic , neurologic , psychiatric disease . History clinically important drug allergy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>